close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Publicis Groupe Launches SSF Group

Famed creative networks Saatchi & Saatchi and Fallon form dynamic new entity to champion creativity and propel growth

PARIS, August 1, 2007 — Publicis Groupe today announced the creation of a new mini group structure, bringing Saatchi & Saatchi together with Fallon in a new alliance to be known as the SSF Group. Under this new structure, both agencies will continue to operate separately and remain stand-alone brands.

Publicis Groupe Chairman and CEO Maurice Levy said, “This new group is a unique partnership of two of the most acclaimed creative agencies in the entire industry and enables both networks to maximize the potential of their creative resources at a global level.” Levy explained, “Pat Fallon has been a true creative trailblazer of our industry, a respected leader who has tirelessly pursued creativity, innovation and excellence – and I’m proud that we have built up a close friendship. From the groundbreaking BMW Films to the celebrated Sony “Balls”, Fallon has been challenging every convention in the category for the last 26 years. With this alliance, the Fallon network is entering into a new exciting phase of its history. Under Kevin Roberts, Saatchi & Saatchi is recording unprecedented growth, and is now one of the fastest growing and most creative networks in the world. I am confident that the new structure will usher in a new era of powerful growth for Fallon and Saatchi & Saatchi.”

The SSF Group will operate under the leadership of Kevin Roberts, Saatchi & Saatchi Worldwide Chief Executive Officer. Kevin Roberts said, “I’ve admired Fallon since I got into this business. Fallon is an iconic brand full of irreverence, courage and smarts. I’m honored to have the chance to work with Fallon’s leadership on taking the brand forward.”

Pat Fallon will become Chairman Emeritus of Fallon Worldwide and play an active advisory role in the new group’s direction. Pat Fallon said, “The creation of this alliance acknowledges our admiration for Kevin Roberts and the success of the Saatchi & Saatchi organization. A closer relationship between the two agencies will help our growth, provide development opportunities for our people, and ensure a bright future for Fallon as a standalone brand, while continuing to deliver the best to our clients.”

Fallon’s Minneapolis headquarters team, invigorated by the recently appointed creative leadership of Al Kelly and Todd Riddle, will report to the SSF Group, but remain otherwise unchanged. SSF will work with the Minneapolis leadership to build on Fallon’s great legacy and regain its position as a leading competitive force in America’s rapidly changing marketing environment.

Robert Senior, a founding partner of Fallon London, will become CEO for the SSF Group in the UK, and report to Roberts. Fallon London has established a strong reputation for its acclaimed creative output and business growth with clients including Sony, Orange, BBC, VW’s Skoda, Eurostar, and Walmart's Asda. As a result of these accomplishments Fallon London was named Campaign magazine's 2006 Agency of the Year. Saatchi & Saatchi London is perhaps the most famous name in British advertising, having proven for 37 years that “Nothing is Impossible.”

Robert Senior said, “Saatchi & Saatchi and Fallon are powerful, distinctive brands with many differences, but they share a higher-order purpose of championing creativity.” He continued, “Our intention is to celebrate our differences, embrace operational advantages, and unite behind the common cause of creativity. There will be developmental opportunities for the people in both brands as well as intriguing possibilities to enhance our offerings domestically and globally for our respective clients.” This announcement coincides with two other top level moves at Saatchi & Saatchi: Jim O’Mahony will become CEO of CRIB (China, Russia, India, Brazil). O’Mahony will focus on driving explosive growth in these key countries. He will look to extend the brand’s leadership position in China and Brazil to Russia and India by driving best practice across each of these rapidly developing economies.

Simon Francis joins Saatchi & Saatchi to bring his own brand of dynamic leadership to Saatchi’s EMEA business. As EMEA CEO, Simon’s focus will be on continued rapid growth in the Middle East and Africa, while repositioning Saatchi & Saatchi for growth in major European markets, Germany, France, Italy, Switzerland and Spain. Jim O’Mahony and Simon Francis will report to Kevin Roberts.

# # # About Publicis Groupe Publicis Groupe (Euronext Paris: FR0000130577 and NYSE: PUB) is the world’s fourth largest communications group, as well as world’s second largest media counsel and buying group. With activities spanning 104 countries on five continents, the Groupe employs approximately 42,000 professionals.

The Groupe’s communication activities cover advertising, through three autonomous global advertising networks: Leo Burnett, Publicis, Saatchi & Saatchi, as well as through its two multi-hub networks Fallon Worldwide and 49%-owned Bartle Bogle Hegarty; media consultancy and buying through two worldwide networks ZenithOptimedia and Starcom MediaVest Group; interactive and digital marketing, marketing services and specialized communications including direct marketing, public relations, corporate and financial communications, event communications, multicultural and with a worldwide leadership in healthcare communications. Web site: www.publicisgroupe.com About Saatchi & Saatchi Saatchi & Saatchi is a global network with 153 offices and part of Publicis Groupe, the world’s fourth largest communications group. Recently awarded the JCPenney and Wendy's businesses, its New York office was named “2007 Agency of the Year” at Cannes and Clio international ad festivals. The Agency handles over 40 #1 brands in its client portfolio, including Toyota; Tide, Pampers and Olay (Procter & Gamble); and Sony Ericsson. Saatchi & Saatchi is known for its exceptional strength at understanding the emotional connections between consumers and products. This approach comes to life through Lovemarks, the methodology created to create "loyalty beyond reason" and "inspirational consumers."

Web site: www.saatchi.com About Fallon Worldwide Fallon Worldwide, one of the world’s most critically acclaimed, creatively driven branding companies, manages the consumer voice of some of the world’s leading brands, including Orange, Travelers, Sony, Nestlé Purina, Asda, Holiday Inn, Holiday Inn Express, TIME Magazine, BBC, Garmin, National Car Rental, and Alamo Rent A Car. Fallon Worldwide has 500 employees worldwide. Web site: www.fallon.com.

Contacts Publicis Groupe Eve Magnant, Corporate Communications + 33 (0)1 44 43 70 25 Martine Hue, Investor Relations + 33 (0)1 44 43 65 00 Fallon Worldwide

Rosemary Abendroth Office: + 1 612 758 2765 Mobile: + 1 612 877 0380 Saatchi & Saatchi NY

Lynne Collins Office: +1 212 463 2734 Mobile: 1 646 286 4724 Saatchi & Saatchi UK

Eleanor Conroy Office: + 44 (0)20 74 627 055 Mobile: +44 77 40 039 886

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...